Prostatic Neoplasms
📧 Sign up to get email alerts when something new happens for Prostatic Neoplasms.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-01-29Clinical Trial Update: Effect of Modified Citrus Pectin on PSA Kinetics in Biochemical Relapsed PC With Serial Increases in PSA [Phase 2]
Phase 2 clinical trial evaluating the effect of modified citrus pectin on PSA kinetics in biochemically recurrent prostate cancer after PSA …
-
CLINICAL_TRIALS trial_result · 2019-11-08Clinical Trial Update: Cabozantinib Plus Docetaxel and Prednisone for Advanced Prostate Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating cabozantinib plus docetaxel and prednisone in advanced prostate cancer has completed with results posted…
-
EMA withdrawal · 2019-10-15EMA Withdrawn: Taxespira (previously Docetaxel Hospira UK Limited ) (docetaxel trihydrate) — Hospira UK Limited
The EMA withdrew Taxespira (docetaxel trihydrate) from the market for multiple cancer indications including stomach, prostate, breast, head …
-
CLINICAL_TRIALS trial_result · 2019-08-01Clinical Trial Update: A Pilot Study of Hormonal Therapy Combined With Central Memory T Cells (Tcm) for Patients With Advanced Prostate Cancer [Phase 1, Phase 2]
A pilot study evaluating hormonal therapy in combination with central memory T cells for advanced prostate cancer (Phase 1/2).
-
EMA withdrawal · 2019-07-24EMA Refused: Cabazitaxel Teva (cabazitaxel) — Teva B.V.
The EMA refused the cabazitaxel product Teva B.V. for therapeutic use in prostatic neoplasms.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-07-10Clinical Trial Update: Sipuleucel-T, CT-011, and Cyclophosphamide for Advanced Prostate Cancer [Phase 2]
Phase 2 clinical trial update investigating sipuleucel-T, CT-011, and cyclophosphamide for advanced prostate cancer has been terminated with…
-
CLINICAL_TRIALS trial_result · 2019-06-12Clinical Trial Update: Endothelial Function in Prostate Cancer Patients on Degarelix vs. Luteinizing Hormone-Releasing Hormone Agonists [Phase 4]
Phase 4 clinical trial assessing endothelial function in prostate cancer patients treated with degarelix versus LHRH agonists; completed.
-
CLINICAL_TRIALS trial_result · 2019-05-20Clinical Trial Update: Can Hyperbaric Oxygen Improve Erectile Function Following Surgery for Prostate Cancer [Phase 4]
Phase 4 clinical trial evaluating whether hyperbaric oxygen therapy can improve erectile function after prostate cancer surgery.
-
CLINICAL_TRIALS trial_result · 2019-05-08Clinical Trial Update: Targeted Fusion Biopsy of the Prostate [Phase 2]
Phase 2 clinical trial update on targeted fusion biopsy for prostate cancer (prostatic neoplasms) completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-01-31Clinical Trial Update: SmartTarget: BIOPSY [NA]
Completed clinical trial update for SmartTarget: BIOPSY conducted by University College London.
-
CLINICAL_TRIALS trial_result · 2019-01-08Clinical Trial Update: Multi-Center Trial of High-resolution Transrectal Ultrasound Versus Standard Low-resolution Transrectal Ultrasound for the Identification of Clinically Significant Prostate Cancer [NA]
A completed multi-center trial comparing high-resolution transrectal ultrasound to standard low-resolution ultrasound for identifying clinic…
-
CLINICAL_TRIALS research · 2018-10-26Clinical Trial Update: Retrospective Observational Study Investigating Fluciclovine (18F) (FACBC)
A retrospective observational study on fluciclovine (18F) FACBC in prostate cancer has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2018-10-12Clinical Trial Update: Vaccine Plus Booster Shots in Men With Prostate Cancer Undergoing Treatment With Radical Prostatectomy [Phase 2]
Phase 2 clinical trial update evaluating vaccine plus booster shots in men with prostate cancer undergoing radical prostatectomy.
-
CLINICAL_TRIALS trial_result · 2018-10-11Clinical Trial Update: Hormone Therapy Plus Chemotherapy as Initial Treatment for Local Failures or Advanced Prostate Cancer [Phase 2]
Phase 2 trial investigating hormone therapy plus chemotherapy as initial treatment for local failures or advanced prostate cancer; the study…
-
CLINICAL_TRIALS trial_result · 2018-09-12Clinical Trial Update: Open-Label Safety Extension Study in Patients Who Have Previously Participated and Have Benefited From LMIS 50 mg [Phase 3]
Open-label safety extension study for LMIS 50 mg in patients with prostatic neoplasms, completed with posted results.
-
CLINICAL_TRIALS trial_result · 2018-04-13Clinical Trial Update: Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate in Subjects With Advanced Prostate Carcinoma [Phase 3]
A Phase 3 trial evaluating safety, efficacy, and pharmacokinetics of leuprolide mesylate in subjects with advanced prostate cancer has compl…
-
CLINICAL_TRIALS trial_result · 2018-02-14Clinical Trial Update: Study of Antioxidants on MRI Detectable Early Stage Prostate Cancer Among Men on Active Surveillance [Phase 2]
Phase 2 trial evaluating antioxidants for MRI-detectable changes in early stage prostate cancer among men on active surveillance; study comp…
-
CLINICAL_TRIALS trial_result · 2017-12-28Clinical Trial Update: A Study With BIBF 1120 in Patients With Hormone Refractory Prostate Cancer [Phase 2]
Phase 2 clinical trial update for BIBF 1120 in hormone-refractory prostate cancer has completed.
-
EMA withdrawal · 2016-09-29EMA Application withdrawn: Docetaxel SUN — Sun Pharmaceutical Industries Europe B.V.
The EMA withdrew the application for Docetaxel SUN by Sun Pharmaceutical Industries Europe B.V. for multiple cancer indications.
-
CLINICAL_TRIALS trial_result · 2015-11-18Clinical Trial Update: Symptoms and Quality of Life (QoL) After Palliative Pelvic Radiation of Prostate and Rectal Cancers
A completed clinical trial update reporting on symptoms and quality of life after palliative pelvic radiation in men with prostate cancer an…
-
CLINICAL_TRIALS trial_result · 2015-06-04Clinical Trial Update: The Effects of Lycopene on High Risk Prostatic Tissue [Phase 2]
Phase 2 trial evaluating the effects of lycopene on high-risk prostatic tissue has completed with results posted.
-
EMA withdrawal · 2015-03-12EMA Lapsed: Docetaxel Mylan (docetaxel) — Mylan S.A.S.
EMA status shows Docetaxel Mylan has lapsed; related indications include head and neck neoplasms, non-small cell lung carcinoma, adenocarcin…
-
EMA withdrawal · 2012-06-14EMA Withdrawn: Docefrez (docetaxel) — Sun Pharmaceutical Industries Europe B.V.
Withdrawn EMA entry for Docefrez (docetaxel) by Sun Pharmaceutical Industries Europe B.V.; listed indications include stomach neoplasms, ade…
-
EMA withdrawal · 2010-03-26EMA Application withdrawn: Docetaxel Mylan (docetaxel) — Mylan S.A.S.
Withdrawal of the EMA application for Docetaxel Mylan (docetaxel) by Mylan S.A.S., affecting multiple solid tumor indications including non-…
-
EMA withdrawal · 2008-08-05EMA Application withdrawn: Orplatna (satraplatin) — Pharmion Ltd.
The EMA withdrew the application for Orplatna (satraplatin) from Pharmion Ltd., with the therapeutic area listed as prostatic neoplasms.